GLP-1 receptor agonists were originally developed in the early 2000s to treat type 2 diabetes. Over time, researchers discovered the drugs also produced significant weight loss, and the list of approved uses has grown steadily since.
Bobby Falat is a Morning News Producer at WAOW. He specializes in themes related to education, continuous education, business and economics, as well as construction and real estate, often covering events and conferences within these sectors. Bobby's work has been featured in KFYR-TV, KVLY-TV, WILX-TV, and WFLX FOX 29.













